Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in RAPP held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 7.2M | $298.9M | +0.1% | 14.998% | 0.01% |
| 2 | TRV GP V, LLC | 6.3M | $261.7M | -12.0% | 13.132% | 52.53% |
| 3 | ARCH Venture Management, LLC | 3.7M | $155.4M | 0.0% | 7.796% | 14.12% |
| 4 | Capital International Investors | 2.9M | $121.8M | -5.7% | 6.109% | 0.03% |
| 5 | GOLDMAN SACHS GROUP INC | 2.9M | $121.3M | -1.1% | 6.085% | 0.01% |
| 6 | BlackRock, Inc. | 2.7M | $112.5M | +7.7% | 5.645% | 0.00% |
| 7 | Cormorant Asset Management, LP | 2.7M | $110.7M | -10.1% | 5.557% | 5.67% |
| 8 | Sofinnova Investments, Inc. | 1.9M | $79.4M | 0.0% | 3.982% | 4.10% |
| 9 | JOHNSON & JOHNSON | 1.8M | $74.4M | 0.0% | 3.731% | 9.31% |
| 10 | Polar Capital Holdings Plc | 1.6M | $67.0M | -2.1% | 3.363% | 0.16% |
| 11 | BAKER BROS. ADVISORS LP | 1.5M | $64.5M | 0.0% | 3.235% | 0.32% |
| 12 | VANGUARD CAPITAL MANAGEMENT LLC | 1.3M | $56.1M | +1.6% | 2.815% | 0.00% |
| 13 | TRV GP VI, LLC | 969K | $40.4M | 0.0% | 2.026% | 17.39% |
| 14 | STATE STREET CORP | 819K | $34.1M | +7.8% | 1.712% | 0.00% |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 793K | $33.1M | +10.0% | 1.659% | 0.00% |
| 16 | PERCEPTIVE ADVISORS LLC | 773K | $32.2M | +14.8% | 1.617% | 0.48% |
| 17 | Vestal Point Capital, LP | 730K | $30.4M | -49.2% | 1.526% | 0.71% |
| 18 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME | 644K | $26.8M | -29.9% | 1.347% | 0.00% |
| 19 | Siren, L.L.C. | 641K | $26.7M | 0.0% | 1.341% | 0.54% |
| 20 | Capital World Investors | 552K | $23.0M | +2.8% | 1.153% | 0.00% |
| 21 | ALLIANCEBERNSTEIN L.P. | 693K | $21.7M | -4.7% | 1.450% | 0.01% |
| 22 | DIMENSIONAL FUND ADVISORS LP | 362K | $15.1M | +61.3% | 0.757% | 0.00% |
| 23 | VANGUARD PORTFOLIO MANAGEMENT LLC | 360K | $15.0M | +12.2% | 0.753% | 0.00% |
| 24 | Candriam S.C.A. | 348K | $14.5M | +87.0% | 0.727% | 0.07% |
| 25 | Sio Capital Management, LLC | 308K | $12.8M | -16.1% | 0.643% | 2.12% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in RAPP — a direct measure of their conviction.
Filings activity in RAPP during Q2 2026, grouped by how each filer changed its position.
Institutions that opened a new RAPP position in Q2 2026
Institutions that fully closed their RAPP position in Q2 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 159 | +7.4% | 107.20% | 2.94 pp | $2.08B | +30% |
| Q1 2026 | 148 | +3.5% | 110.14% | +3.64 pp | $1.60B | +6.1% |
| Q4 2025 | 143 | +17% | 106.50% | +1.91 pp | $1.50B | +5.8% |
| Q3 2025 | 122 | +49% | 104.59% | 1.16 pp | $1.42B | +244% |
| Q2 2025 | 82 | +6.5% | 105.75% | +1.73 pp | $413M | +17% |
| Q1 2025 | 77 | +10% | 104.02% | +3.76 pp | $353M | 41% |
| Q4 2024 | 70 | +27% | 100.26% | +22.48 pp | $599M | +15% |
| Q3 2024 | 55 | — | 77.78% | — | $523M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Institutional ownership and quarterly buying activity across the largest Neuroscience Biotech peers.
Quick answers to the most common questions about buying RAPP stock.
Based on Q2 2026 13F filings, institutional ownership of Rapport Therapeutics, Inc. Common Stock stands at 107.2%, held across 159 reporting institutions.
FMR LLC is the largest reported institutional holder of RAPP, with approximately 7,172,894 shares worth $0.30B as of Q2 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of RAPP.
Our composite Smart Money Score for RAPP is 32 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
24 institutions opened new positions in RAPP during Q2 2026, while 12 fully exited. 117 added to existing positions and 14 trimmed.
RAPP institutional ownership fell by 2.94 percentage points quarter-over-quarter, with a net change of +11 holders.
The top 10 institutions account for 67.5% of all reported 13F value in RAPP, and the top 25 account for 88.9%.
Across the largest Neuroscience Biotech peers, institutional ownership levels are: DFTX (89.1%), HELP (49.7%), KRSA (10.0%), FLNA (28.5%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.